A countless number of CBD companies state that CBD (cannabidiol) is “non-psychoactive.” The frequency with which this announcement is replicated rises as the use of CBD becomes more prevalent. Many brands using the expression “non-psychoactive” probably mean to state CBD is “not intoxicating”. That is certainly correct. However, to say that CBD is “non-psychoactive” is not only inaccurate. It is the opposite of the truth! CBD is psychoactive (and you can stop saying that it isn’t). A compound is deemed psychoactive as it functions chiefly on the central nervous system and effects brain function, leading to temporary changes in perception, mood, consciousness or behavior. CBD doesn’t have the synergistic impact of THC and doesn’t lead to noticeable cognitive alterations or withdrawal effects. On the other hand CBD does cross the blood brain barrier and it also directly impacts the central nervous system with consequent changes in perception and mood. The endocannabinoid system (ECS) contains various endocannabinoids − receptors which bind to receptors through the central nervous system and peripheral nervous system. The ECS helps modulate numerous cognitive and physiological processes within the human anatomy, such as hunger, pain, anxiety reaction, memory and mood. The cannabis plant includes heaps of cannabinoids that bind with ECS receptors. Both principal receptors for cannabinoids are known as the CB1 and CB2. They help regulate coordination, mood, pain, hunger and certain additional purposes. CB2 receptors are located throughout the entire body and are common from the immune system. They mostly have an effect on pain and inflammation. This causes an exaggerated mood reaction connected with feelings of euphoria. CBD has a more regulating influence on the receptors compared to THC. It interacts with CB1, which ends in mild stimulation or obstructing of this receptor. CBD acts as a modulator that could amplify or reduce the receptor’s ability to transmit signals, much like a dimmer switch. It’s believed that this modulation of brain activity might be the foundation for CBD’s capacity to reduce seizures as well as the symptoms related to mood disorders like depression and anxiety. This activity is also considered to activate the body to make more CB receptors, leading to elevated natural levels of anandamide. With more CB receptors, the human body becomes more sensitive to normal endocannabinoids currently within the body. CBD modulates the CB1 receptor only in the presence of either THC or a different cannabinoid which also binds to the receptor.